The effects of vinblastine on the expression of human immunodeficiency virus type 1 long terminal repeat

Ender Akan, Chin Mei Chang-Liu, Jobu Watanabe, Kota Ishizawa, Gayle E. Woloschak

研究成果: Article査読

3 被引用数 (Scopus)


Previous work by our group has demonstrated induction of the HIV-LTR following exposure of cells to various DNA-damaging agents such as ultraviolet (UV) light, cisplatin, and doxorubicin. The current experiments were designed to determine the relative effects of the anti-mitotic drug vinblastine on expression of the HIV-LTR. Using human cervical carcinoma (HeLa) cells stably transfected with the chloramphenicol acetyl transferase (CAT) reporter transcriptionally driven by the HIV-LTR promoter, we demonstrated a 9-10-fold induction at 48-72 h following vinblastine treatment. Previous experiments had demonstrated repression of cisplatin or doxorubicin-mediated HIV induction by treatment with salicylic acid. The vinblastine induction also was repressed by salicylic acid treatment, but not by treatment with indomethacin, suggesting a role for the NFκB pathway in the inductive response. When UV exposure was coupled to the vinblastine treatment, there was no additive or synergistic effect evident, suggesting similar paths of induction between the two agents. Northern blots demonstrated that these agents were operating at the level of transcription and that salicylic acid inhibited vinblastine-mediated induction of HIV-LTR-CAT mRNA only if administered at the same time as vinblastine; addition of salicylic acid 2 h later had no effect on transcript accumulation. All combinations of treatments with vinblastine and/or salicylic acid markedly reduced cell survival.

ジャーナルLeukemia Research
出版ステータスPublished - 1997 5 1

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

フィンガープリント 「The effects of vinblastine on the expression of human immunodeficiency virus type 1 long terminal repeat」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。